Therapeutic Potential of Mesenchymal Stem Cells for the Treatment of Airway Remodeling in Pulmonary Diseases
-
Amir Nejad-Moghaddam
,
Yunes Panahi
,
Meghdad Abdollahpour Alitappeh
,
Hojat Borna
,
Mohammad Ali Shokrgozar
,
Mostafa Ghanei
Abstract
According to significant improvements in the tissue engineering field over the past several years, lung tissue cells have recently attracted more attention due to the high prevalence and diversity in related diseases. However, selection of an appropriate cell type, screening of suitable conditions for growth and proliferation, as well as subsequent implantation into the body to repair and regenerate damaged tissues are considered as important issues in this context. It should also be noted that most studies have been described in animal models, but not in humans. Because of the high regenerative capacity, predominant immunomodulatory feature, and inhibition of T-lymphocyte proliferation, mesenchymal stem cells (MSCs) may play an important role in the reconstruction of damaged tissues including bronchioles in pulmonary diseases. Interestingly, clinical trial studies demonstrated that MSCs have the significant potential to treat a wide variety of diseases including acute myocardial infarction (AMI), liver cirrhosis, crohn’s disease, and graft-versus-host disease (GVHD).
1. Balharry D, Sexton K, BéruBé KA. An in vitro approach to assess the toxicity of inhaled tobacco smoke components: nicotine, cadmium, formaldehyde and urethane. Toxicology 2008; 244(1):66-76.
2. BéruBé K, et al., Characterisation of airborne particulate matter and related mechanisms of toxicity: an experimental approach. Air pollution reviews, 2006. 3: p. 69-109.
3. BeruBe K, Jones T, Jones C. Environmental Particles: A Breath of Fresh Air? Infocus Magazine 2008; (9):4.
4. Tuder RM, McGrath S, Neptune E. The pathobiological mechanisms of emphysema models: what do they have in common? Pulm Pharmacol Ther 2003; 16(2):67-78.
5. Sato K, Ozaki K, Mori M, Muroi K, Ozawa K.Mesenchymal stromal cells for graft-versus-host disease : basic aspects and clinical outcomes. J Clin Exp Hematop 2010; 50(2):79-89.
6. Snyder JC, Teisanu RM, Stripp BR. Endogenous lung stem cells and contribution to disease. J Pathol 2009;217(2):254-64.
7. Lee J, Reddy R, Barsky L, Weinberg K, Driscoll B.Contribution of proliferation and DNA damage repair to alveolar epithelial type 2 cell recovery from hyperoxia. Am J Physiol Lung Cell Mol Physiol 2006;290(4):L685-L694.
8. Reddy R, Buckley S, Doerken M, Barsky L, Weinberg K, Anderson KD, et al. Isolation of a putative progenitor subpopulation of alveolar epithelial type 2 cells. Am J Physiol Lung Cell Mol Physiol 2004; 286(4):L658-67.
9. Coraux C, Nawrocki-Raby B, Hinnrasky J, Kileztky C, Gaillard D, Dani C, et al. Embryonic stem cells generate airway epithelial tissue. Am J Respir Cell Mol Biol 2005; 32(2):87-92.
10. Rippon HJ, Polak JM, Qin M, Bishop AE. Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells 2006; 24(5):1389-98.
11. Tashiro K, Inamura M, Kawabata K, Sakurai F, Yamanishi K, Hayakawa T, et al. Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 2009; 27(8):1802-11.
12. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007; 179(3):1855-63.
13. Sueblinvong V, Loi R, Eisenhauer PL, Bernstein IM, Suratt BT, Spees JL, et al. Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. Am J Respir Crit Care Med 2008; 177(7):701-11.
14. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4):315-7.
15. Salem HK, Thiemermann C. Thiemermann, Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28(3):585-96.
16. Martens TP, See F, Schuster MD, Sondermeijer HP, Hefti MM, Zannettino A, et al. Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat Clin Pract Cardiovasc Med 2006; (3 Suppl 1):S18-22.
17. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110(10):3499-506.
18. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 2008; 180(4):2581-7.
19. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105(1):93-8.
20. Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007;21(12):3197-207.
21. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105(4):1815-22.
22. Mohamadnejad M, Alimoghaddam K, Mohyeddin- Bonab M, Bagheri M, Bashtar M, Ghanaati H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007; 10(4):459-66.
23. García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005; 48(7):1416-23.
24. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363(9419):1439-41.
25. Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH.Immunomodulation by mesenchymal stem cells a potential therapeutic strategy for type 1 diabetes. Diabetes 2008; 57(7):1759-67.
26. Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen‐induced arthritis. Arthritis Rheum 2007;56(4):1175-86.
27. D'Agostino B, Sullo N, Siniscalco D, De Angelis A, Rossi F. Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opin Biol Ther 2010; 10(5):681-7.
28. Breuer R, Zajicek G, Christensen TG, Lucey EC, Snider GL. Cell kinetics of normal adult hamster bronchial epithelium in the steady state. Am J Respir Cell Mol Biol 1990; 2(1):51-8.
29. Rock JR, Randell SH, Hogan BL. Hogan, Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech 2010;3(9-10):545-56.
30. Zhang YV, Cheong J, Ciapurin N, McDermitt DJ, Tumbar T. Distinct self-renewal and differentiation phases in the niche of infrequently dividing hair follicle stem cells. Cell Stem Cell 2009; 5(3):267-78.
31. Erjefält JS, Persson CG. Airway epithelial repair: breathtakingly quick and multipotentially pathogenic. Thorax 1997; 52(11):1010-2.
32. Hong KU, Reynolds SD, Giangreco A, Hurley CM, Stripp BR. Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 2001; 24(6):671-81.
33. Shimizu T, Nishihara M, Kawaguchi S, Sakakura Y.Expression of phenotypic markers during regeneration of rat tracheal epithelium following mechanical injury. Am J Respir Cell Mol Biol 1994; 11(1):85-94.
34. Chary P, Mitchell CE, and Kelly G, Chemical carcinogen-induced damage to the c-neu and c-myc protooncogenes in rat lung epithelial cells: possible mechanisms for differential repair in transcriptionally active genes. Cancer Lett, 1991. 58(1-2): p 57-63.
35. Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010;298(6):L715-31.
36. Geiser T. Mechanisms of alveolar epithelial repair in acute lung injury--a translational approach. Swiss Med Wkly 2003; 133(43-44):586-90.
37. Bergeron C, Tulic MK, Hamid Q. Tools used to measure airway remodelling in research. Eur Respir J 2007;29(3):596-604.
38. Busse W, Elias J, Sheppard D, Banks-Schlegel S.Airway remodeling and repair. Am J Respir Crit Care Med 1999; 160(3):1035-42.
39. Puchelle E, Zahm JM, Tournier JM, Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3(8):726-33.
40. Postma DS, Timens W. Timens, Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3(5):434-9.
41. Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST, et al. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997; 156(2 Pt1):642-7.
42. Aubert JD, Dalal BI, Bai TR, Roberts CR, Hayashi S, Hogg JC. Transforming growth factor beta 1 gene expression in human airways. Thorax 1994; 49(3):225-32.
43. El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, et al. Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999;18(9):828-37.
44. Königshoff M, Kneidinger N, Eickelberg O. TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen. Swiss Med Wkly 2009; 139(39-40):554-63.
45. Churg A, Wang RD, Tai H, Wang X, Xie C, Dai J, et al.Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor- alpha release. Am J Respir Crit Care Med 2003;167(8):1083-9.
46. Elias JA, Kang MJ, Crothers K, Homer R, Lee CG. State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice. Proc Am Thorac Soc 2006; 3(6):494-8.
47. Srivastava PK, Dastidar SG, Ray A. Chronic obstructive pulmonary disease: role of matrix metalloproteases and future challenges of drug therapy. Expert Opin Investig Drugs 2007; 16(7):1069-78.
48. Rawlins EL, Okubo T, Que J, Xue Y, Clark C, Luo X, et al. Epithelial stem/progenitor cells in lung postnatal growth, maintenance, and repair. Cold Spring Harb Symp Quant Biol 2008; 73:291-5.
49. Burgess JK. The role of the extracellular matrix and specific growth factors in the regulation of inflammation and remodelling in asthma. Pharmacol Ther 2009;122(1):19-29.
50. Holm AM, Riise GC, Brinch L, Bjørtuft O, Iversen M, Simonsen S, et al. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: unresolved questions. Transplantation 2013; 96(4):e21-2.
51. Tzortzaki EG, Siafakas NM. A hypothesis for the initiation of COPD. Eur Respir J 2009; 34(2):310-5.
52. Williams KM, Chien JW, Gladwin MT, Pavletic SZ.Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA 2009; 302(3):306-14.
53. Hong KU, Reynolds SD, Giangreco A, Hurley CM,Stripp BR. Clara cell secretory protein–expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 2001; 24(6):671-81.
54. Evans MJ, Shami SG, Cabral-Anderson LJ, Dekker NP.Role of nonciliated cells in renewal of the bronchial epithelium of rats exposed to NO2. Am J Pathol 1986;123(1):126-33.
55. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al., Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003; 100(14):8407-11.
56. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER.Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982; 126(2):332-337.
57. Lee CG, Homer RJ, Cohn L, Link H, Jung S, Craft JE, et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and- independent pathways. J Biol Chem 2002;277(38):35466-74.
58. Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC, et al. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000;22(6):649-56.
59. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103(6):779-88.
60. Minguell JJ, Conget P, Erices A. Biology and clinical utilization of mesenchymal progenitor cells. Braz J Med Biol Res 2000; 33(8):881-7.
61. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med (Maywood) 2001; 226(6):507-20.
62. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem cells 2001; 19(3):180-92.
63. Fridenshteĭn AIa, Luriia EA. [Cellular basis of the hematopoietic microenvironment]. Ter Arkh 1980;52(9):67-71.
64. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418(6893):41-9.
65. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. science 1999;284(5411):143-7.
66. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008; 26(9):2287-99.
67. Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T- cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005; 90(4):516-25.
68. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007; 109(1):228-34.
69. Sato T, Hidaka K, Iwanaga A, Ito M, Asano M, Nakabeppu Y, et al. Impairment of cardiomyogenesis in embryonic stem cells lacking scaffold protein JSAP1. Biochem Biophys Res Commun 2005; 338(2):1152-7.
70. Ghazanfari, S., et al. Analysis of alterations in morphologic characteristics of mesenchymal stem cells by mechanical stimulation during differentiation into smooth muscle cells. Yakhteh Medical Journal 2010;12(1):73-80.
71. Bayati V, Sadeghi Y, Shokrgozar MA, Haghighipour N, Azadmanesh K, Amanzadeh A, et al. The evaluation of cyclic uniaxial strain on myogenic differentiation of adipose-derived stem cells. Tissue Cell 2011; 43(6):359-66.
72. Haghighipour N, Heidarian S, Shokrgozar MA, Amirizadeh N. Differential effects of cyclic uniaxial stretch on human mesenchymal stem cell into skeletal muscle cell. Cell Biol Int 2012; 36(7):669-75.
73. Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262(5):509-25.
74. Miura M1, Miura Y, Padilla-Nash HM, Molinolo AA, Fu B, Patel V, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 2006; 24(4):1095-103.
75. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells< sup>,</sup>. Bone 2003; 33(6):919-26.
76. Löbel M, Bauer S, Meisel C, Eisenreich A, Kudernatsch R, Tank J, et al. CCN1: a novel inflammation-regulated biphasic immune cell migration modulator. Cell Mol Life Sci 2012; 69(18):3101-13.
77. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol 2005; 6(12):1182-90.
78. Salcedo R, Oppenheim JJ. Oppenheim, Role of chemokines in angiogenesis: CXCL12/SDF‐1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 2003; 10(3‐4):359-70.
79. Spring H, Schüler T, Arnold B, Hämmerling GJ, Ganss R. Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci U S A 2005;102(50):18111-6.
80. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005; 106(2):419-27.
81. Rüster B, Göttig S, Ludwig RJ, Bistrian R, Müller S,Seifried E, et al. Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood 2006; 108(12):3938-44.
82. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005; 106(6):1901-10.
83. Spradling A, Drummond-Barbosa D, Kai T. Stem cells find their niche. Nature 2001; 414(6859):98-104.
84. Lapidot T. Mechanism of human stem cell migration and repopulation of NOD/SCID and B2mnull NOD/SCID mice. The role of SDF-1/CXCR4 interactions. Ann N Y Acad Sci 2001; 938:83-95.
85. Chapel A, Bertho JM, Bensidhoum M, Fouillard L, Young RG, Frick J, et al. Mesenchymal stem cells home to injured tissues when co‐infused with hematopoietic cells to treat a radiation‐induced multi‐organ failure syndrome. J Gene Med 2003; 5(12):1028-38.
86. Conget PA, Minguell JJ. Minguell, Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999;181(1):67-73.
87. Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J, et al. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 2007; 21(8):1733-8.
88. Shi M, Li J, Liao L, Chen B, Li B, Chen L. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 2007; 92(7):897-904.
89. Baglio SR, Pegtel DM, Baldini N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 2012; 3:359.
90. Hogan NM, Joyce MR, Murphy JM, Barry FP, O'Brien T, Kerin MJ, et al. Impact of mesenchymal stem cell secreted PAI-1 on colon cancer cell migration and proliferation. Biochem Biophys Res Commun 2013;435(4):574-9.
91. von Andrian UH. A massage for the journey: keeping leukocytes soft and silent. Proc Natl Acad Sci U S A 1997; 94(10):4825-7.
92. Von Lüttichau I, Notohamiprodjo M, Wechselberger A, Peters C, Henger A, Seliger C, et al. Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev 2005; 14(3):329-36.
93. Meirelles Lda S, Fontes AM, Covas DT, Caplan AI.Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009; 20(5-6):419-27.
94. Han KH, Ro H, Hong JH, Lee EM, Cho B, Yeom HJ, et al. Immunosuppressive mechanisms of embryonic stem cells and mesenchymal stem cells in alloimmune response. Transpl Immunol 2011; 25(1):7-15.
95. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009; 15(1):42-9.
96. Gebler A, Zabel O, Seliger B. The immunomodulatory capacity of mesenchymal stem cells. Trends Mol Med 2012; 18(2):128-34.
97. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998;176(1):57-66.
98. Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988; 167(2):332-44.
99. Splawski JB, McAnally LM, Lipsky PE. IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2). J Immunol 1990;144(2):562-9.
100. Choi YS, Jeong JA, Lim DS. Mesenchymal stem cell- mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect. Immunol Invest 2012; 41(2):214-29.
101. Lu L, Wang DD, Li X, Zeng XF, Sun LY. [Mechanism of umbilical cord mesenchymal stem cells in the up-regulation of regulatory T cells by transforming growth factor beta1 in systemic lupus erythematosus]. Zhonghua Yi Xue Za Zhi 2013;93(13):980-3.
102. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 2008; 26(1):212-22.
103. Wang L, Li Y, Chen J, Gautam SC, Zhang Z, Lu M, et al. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. Exp Hematol 2002; 30(7):831-6.
104. Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y, et al.MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 2002; 7(2):113-7.
105. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA.Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A 2009; 106(38):16357-62.
106. Bassi, E.J., C.A. Aita, and N.O. Camara, Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand? World J Stem Cells,2011. 3(1): p. 1-8.
107. Mielcarek, M., et al., Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation. Biol Blood Marrow Transplant,2011. 17(2): p. 214-25.
108. Deans, R.J. and A.B. Moseley, Mesenchymal stem cells:biology and potential clinical uses. Exp Hematol, 2000.28(8): p. 875-84.
109. Morandi, F., et al., Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells, 2008. 26(5): p. 1275-87.
110. DelaRosa O, Lombardo E. Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential. Mediators Inflamm 2010; 2010:865601.
111. Lei J, Wang Z, Hui D, Yu W, Zhou D, Xia W, et al.Ligation of TLR2 and TLR4 on murine bone marrow- derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity. Cell Immunol 2011; 271(1):147-56.
112. Liotta F, Angeli R, Cosmi L, Filì L, Manuelli C, Frosali F, et al. Toll‐Like Receptors 3 and 4 Are Expressed by Human Bone Marrow‐Derived Mesenchymal Stem Cells and Can Inhibit Their T‐Cell Modulatory Activity by Impairing Notch Signaling. Stem cells 2008; 26(1):279-89.
113. Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Köppel A, et al. Toll‐Like Receptor Engagement Enhances the Immunosuppressive Properties of Human Bone Marrow‐Derived Mesenchymal Stem Cells by Inducing Indoleamine‐2,3‐dioxygenase‐1 via Interferon‐β and Protein Kinase R.Stem Cells 2009; 27(4):909-919.
114. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006;107(1):367-72.
115. Shi M, Liu ZW, Wang FS. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 2011; 164(1):1-8.
116. Singer NG, Caplan AI. Mesenchymal stem cells:mechanisms of inflammation. Annu Rev Pathol 2011;6:457-78.
117. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2- induced NK-cell proliferation. Blood 2006; 107(4):1484-90.
118. Zhang W, Ge W, Li C, You S, Liao L, Han Q, et al.Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 2004; 13(3):263-71.
119. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101(8):2999-3001.
120. Duffy MM, Ritter T, Ceredig R, Griffin MD.Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther 2011; 2(4):34.
121. Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Nova-Lamperti E, Tejedor G, et al. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 2013; 4(3):65.
122. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31(10):890-6.
123. Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 2007; 84(2):231-7.
124. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006; 24(2):386-98.
125. Jacobs SA, Plessers J, Pinxteren J, Roobrouck VD, Verfaillie CM, Van Gool SW. Mutual interaction between Human Multipotent Adult Progenitor Cells and NK cells. Cell transplant 2014; 23(9):1099-110.
126. Mao F, Xu WR, Qian H, Zhu W, Yan YM, Shao QX, et al. Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis. Inflamm Res 2010; 59(3):219-25.
127. Ramasamy R, Tong CK, Seow HF, Vidyadaran S, Dazzi F. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 2008; 251(2):131-6.
128.Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte- derived dendritic cells. J Immunol 2006; 177(4):2080-7.
129. Krasnodembskaya A Song Y, Fang X, Gupta N, Serikov V, Lee JW, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28(12):2229-38.
130. Sun CK, Yen CH, Lin YC, Tsai TH, Chang LT, Kao YH, et al. Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. J Transl Med 2011; 9:118.
131. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 2007;293(1):L131-41.
132. Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci U S A 2009; 106(31):12771-5.
133. Loi R, Beckett T, Goncz KK, Suratt BT, Weiss DJ.Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med 2006; 173(2):171-9.
134. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105(3):369-77.
135. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 2001; 128(24):5181-8.
136. Loebinger MR, Janes SM. Stem cells for lung disease.Chest 2007; 132(1):279-85.
137. Marshall HE 3rd, Keenan KP, McDowell EM. The stathmokinetic and morphological response of the hamster respiratory epithelium to intralaryngeal instillations of saline and ferric oxide in saline. Fundam Appl Toxicol 1987; 9(4):705-14.
138. Kauffman SL. Cell proliferation in the mammalian lung.Int Rev Exp Pathol 1980; 22:131-91.
139. Breuer R, Christensen TG, Wax Y, Bolbochan G, Lucey EC, Stone PJ, et al. Relationship of secretory granule content and proliferative intensity in the secretory compartment of the hamster bronchial epithelium. Am J Respir Cell Mol Biol 1993; 8(5):480-5.
140. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M,Tashkin DP. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013;143(6):1590-8.
141. Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY,et al. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 2011; 20(8):1297-308.
142. Angelini DJ, Dorsey RM, Willis KL, Hong C, Moyer RA, Oyler J, et al. Chemical warfare agent and biological toxin-induced pulmonary toxicity: could stem cells provide potential therapies? Inhal Toxicol 2013;25(1):37-62.
143. Liang, W., H. Xia, Y. Wang, Allogeneic Mesenchymal Stem Cells Injections for the Treatment of Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cells Transplant. J Cancer Sci Ther 2012:4-7.
144. Serikov VB, Popov B, Mikhailov VM, Gupta N,Matthay MA. Evidence of temporary airway epithelial repopulation and rare clonal formation by BM-derived cells following naphthalene injury in mice. Anat Rec 2007; 290(9):1033-45.
145. Gomperts BN, Belperio JA, Fishbein MC, Keane MP,Burdick MD, Strieter RM. Keratinocyte growth factor improves repair in the injured tracheal epithelium. Am J Respir Cell Mol Biol 2007; 37(1):48-56.
146. Tzouvelekis A, Koliakos G, Ntolios P, Baira I, Bouros E, Oikonomou A, et al. Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal. J Transl Med 2011; 9:182.
147. Nichols JE, Niles JA, Cortiella J. Production and utilization of acellular lung scaffolds in tissue engineering. J Cell Biochem 2012; 113(7):2185-92.
148. Leblond AL, Naud P, Forest V, Gourden C, Sagan C, Romefort B, et al. Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury. Hum Gene Ther 2009; 20(11):1329-43.
149. Wong AP, Dutly AE, Sacher A, Lee H, Hwang DM, Liu M, et al. Targeted cell replacement with bone marrow cells for airway epithelial regeneration. Am J Physiol Lung Cell Mol Physiol 2007; 293(3):L740-52.
150. Grove DA, Xu J, Joodi R, Torres-Gonzales E, Neujahr D, Mora AL, et al. Attenuation of early airway obstruction by mesenchymal stem cells in a murine model of heterotopic tracheal transplantation. J Heart Lung Transplant 2011; 30(3):341-50.
151. Abreu SC, Antunes MA, Maron-Gutierrez T, Cruz FF,Carmo LG, Ornellas DS, et al. Effects of bone marrow-derived mononuclear cells on airway and lung parenchyma remodeling in a murine model of chronic allergic inflammation. Respir Physiol Neurobiol 2011; 175(1):153-63.
152. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G,Go K, et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 2007; 104(26):11002-7.
153. Liang ZX, Sun JP, Wang P, Tian Q, Yang Z, Chen LA.Bone marrow-derived mesenchymal stem cells protect rats from endotoxin-induced acute lung injury. Chin Med J (Engl) 2011; 124(17):2715-22.
154. Yagi H, Soto-Gutierrez A, Kitagawa Y, Tilles AW,Tompkins RG, Yarmush ML. Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant 2010; 19(6):823-30.
155. Zhao F, Zang YF, Liu YG, Zhou JJ, Li ZK, Wu CG, Qi HW,Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin- induced lung injury in rats. Transplant Proc. 2008 Jun;40(5):1700-5.
156. Li J, Li D, Liu X, Tang S, Wei F. Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. J Inflamm (Lond) 2012; 9(1):33.
157. Andrade CF, Wong AP, Waddell TK, Keshavjee S, Liu M. Cell-based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol Physiol 2007;292(2):L510-8.
158. Fang X, Neyrinck AP, Matthay MA, Lee JW.Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem 2010; 285(34):26211-22.
| Files | ||
| Issue | Vol 14, No 6 (2015) | |
| Section | Review Article(s) | |
| Keywords | ||
| Adipose-derived mesenchymal stem cell Airway remodeling Chronic bronchitis Chronic obstructive pulmonary disease Inflammation Lung diseases Mesenchymal stem cell | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
